US Stock MarketDetailed Quotes
ATOS Atossa Therapeutics
- 1.2720
- -0.0180-1.40%
Trading Nov 27 11:54 ET
160.02MMarket Cap-6057P/E (TTM)
1.3200High1.2400Low196.73KVolume1.2700Open1.2900Pre Close253.71KTurnover0.17%Turnover RatioLossP/E (Static)125.80MShares2.310052wk High2.17P/B150.05MFloat Cap0.700052wk Low--Dividend TTM117.97MShs Float2231.9981Historical High--Div YieldTTM6.20%Amplitude0.5000Historical Low1.2890Avg Price1Lot Size
Atossa Therapeutics Key Stats
EPS
According to the latest financial report of Atossa Therapeutics, the latest earnings per share (TTM) for the company is -0.06. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Atossa Therapeutics's free cash flow? The latest report shows it as -4.76M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Atossa Therapeutics shows that the company's current ratio is 13.30, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Atossa Therapeutics, the quick ratio is 12.90, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Atossa Therapeutics? The latest ROE figure is -9.40%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Atossa Therapeutics, the total asset return on investment (ROA) is -8.75%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Atossa Therapeutics's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Atossa Therapeutics, the net profit margin is -282.23K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data